(19)
(11) EP 0 836 610 A1

(12)

(43) Date of publication:
22.04.1998 Bulletin 1998/17

(21) Application number: 96922034.0

(22) Date of filing: 26.06.1996
(51) International Patent Classification (IPC): 
C07H 7/ 02( . )
A61K 31/ 7028( . )
A61P 7/ 02( . )
A61P 9/ 10( . )
A61P 11/ 16( . )
A61P 35/ 00( . )
C07H 17/ 02( . )
A61K 31/ 70( . )
A61K 31/ 7034( . )
A61P 9/ 08( . )
A61P 11/ 00( . )
A61P 29/ 00( . )
C07H 15/ 207( . )
(86) International application number:
PCT/EP1996/002785
(87) International publication number:
WO 1997/001569 (16.01.1997 Gazette 1997/04)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30) Priority: 29.06.1995 CH 19950001914

(71) Applicant: Novartis AG
4058 Basel (CH)

(72) Inventor:
  • KOLB, Hartmuth, Christian
    D-79540 Lörrach (DE)

(74) Representative: Roth, Bernhard M., et al 
Novartis AG Geistiges Eigentum Konzern Patent- und Markenabteilung CH Postfach
4002 Basel
4002 Basel (CH)

   


(54) DIGLYCOSYLATED 1,2-DIOLS AS MIMETICS OF SIALYL-LEWIS X AND SIALYL-LEWIS A